Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proton pump inhibitor plus megestrol versus routine antiemetic treatment for prevention of highly emetogenic chemotherapy-induced nausea and vomiting
ChiCTR1800017953Phase 4Recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esomeprazole, omeprazole, pantoprazole and megestrol in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Henan Cancer Hospital. Primary endpoint: Vomiting control rate. Started May 2017; status: recruiting.
02
Drugs
esomeprazoleomeprazolepantoprazolemegestrol
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ChiCTR1800017953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017953.